Ceptaris Therapeutics
Ceptaris Therapeutics is a pharmaceutical company developing therapeutics for symptoms of early-stage mycosis fungoides.
Ceptaris Therapeutics is active in the biotechnology, health care, medical, therapeutics space based in Greater Philadelphia Area, Great Lakes, Northeastern US, founded in 2002.
The company sits in the biotechnology, health care, medical, therapeutics segment, where it competes on its core product or service.
Its base of operations is Greater Philadelphia Area, Great Lakes, Northeastern US.
Its current recorded stage is Series_D.
Recorded headcount: c_00011_00050 employees.
Public records show total funding of about $64.8M.
| Sector | Biotechnology, Health Care, Medical, Therapeutics |
|---|---|
| Headquarters | Greater Philadelphia Area, Great Lakes, Northeastern US |
| Founded | 2002 |
| Employees | c_00011_00050 |
| Stage | series_d |
| Total funding | $64,790,001 |
Website: www.ceptaris.com
Browse related
Sign in to view the contact information we hold for Ceptaris Therapeutics.
Create a free account
Create a free account